Dr. Umang Swami, MD
Claim this profileHuntsman Cancer Institute/University of Utah
Area of expertise
Prostate Cancer
Umang Swami, MD has run 7 trials for Prostate Cancer. Some of their research focus areas include:
Kidney Cancer
Umang Swami, MD has run 1 trial for Kidney Cancer. Some of their research focus areas include:
Affiliated Hospitals
Huntsman Cancer Institute/University Of Utah
Huntsman Cancer Institute
Clinical Trials Umang Swami, MD is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Cabozantinib + 177Lu-PSMA-617
for Prostate Cancer
This is an open-label, phase 1b dose-escalation study of cabozantinib in combination with 177Lu-PSMA-617 in subjects with mCRPC. The primary hypothesis is that cabozantinib with 177Lu-PSMA will be safe and have efficacy in patients with mCRPC. The dose-escalation phase (Part 1) will assess the rate of dose-limiting toxicities (DLTs) during the DLT evaluation period and identify the MTD and/or recommended dose and schedule for the subsequent expansion phase (Part 2).
Recruiting
1 award
Phase 1
More about Umang Swami, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Umang Swami, MD has experience with
- Cabozantinib
- Enfortumab Vedotin
- Atezolizumab
- Cabozantinib S-malate
- XL092
- Bortezomib
Breakdown of trials Umang Swami, MD has run
Prostate Cancer
Kidney Carcinoma
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Umang Swami, MD specialize in?
Umang Swami, MD focuses on Prostate Cancer and Kidney Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage III.
Is Umang Swami, MD currently recruiting for clinical trials?
Yes, Umang Swami, MD is currently recruiting for 7 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Umang Swami, MD has studied deeply?
Yes, Umang Swami, MD has studied treatments such as Cabozantinib, Enfortumab Vedotin, Atezolizumab.
What is the best way to schedule an appointment with Umang Swami, MD?
Apply for one of the trials that Umang Swami, MD is conducting.
What is the office address of Umang Swami, MD?
The office of Umang Swami, MD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.